ArticleThe pharmacogenomics journal2019

Genetic polymorphisms in ABCG2 and CYP1A2 are associated with imatinib dose reduction in patients treated for gastrointestinal stromal tumors.

Michiel C Verboom et al.PubMed ↗Publisher ↗

No numbers read from the abstract.